Medicinal combination intended for the treatment of obesity, consisting of amphepramone (2-diethylamino-1-phenylpropanone) and fenfluramine (N-ethyl-3-trifluoromethyl-1-phenyl-2-propanamine)

摘要

The invention relates to a medicinal combination of two active principles which is intended for the treatment of obesity. This combination consists of a mixture of amphepramone and fenfluramine. Preferred proportions in this combination are : 2 mg of amphepramone to 1 mg of fenfluramine.